Hypercalcemia due to the interaction between all trans retinoic acid and posaconazole used for acute promyelocytic leukemia treatment

Hypercalcemia due to the interaction between all trans retinoic acid and posaconazole used for acute promyelocytic leukemia treatment

Bibliographic Details
Main Authors:	H. Afacan Öztürk, M. Albayrak, S. Maral, M. Reis Aras, F. YıLmaz, P. Akyol, M. Tiglioglu
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920301942

Similar Items

All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
by: T. M. Anoop, et al.
Published: (2014-07-01)

All-trans-retinoic acid-induced pseudotumor cerebri in acute promyelocytic leukemia
by: T. M. Anoop, et al.
Published: (2014-01-01)

All -Trans-Retinoic Acid–induced pseudotumor cerebri in Acute Promyelocytic Leukemia
by: anoop tm
Published: (2014-08-01)

Hypercalcemia due to concomitant use of all trans retinoic acid and voriconazole
by: A. Koca Yozgat, et al.
Published: (2020-10-01)

Haematologic Parameters In Acute Promyelocytic Leukemia Patients Treated With ALL Trans- Retinoic acid
by: Alaa G. Hussein, et al.
Published: (2007-04-01)

Scrotal ulceration following all-trans retinoic acid therapy for acute promyelocytic leukemia
by: Illias Tazi, et al.
Published: (2011-01-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

Diffuse Pulmonary Alveolar Hemorrhage Secondary to All-Trans-Retinoic Acid in Acute Promyelocytic Leukemia
by: Chen-Lu Yang, et al.
Published: (2018-01-01)

Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01)

All-Trans Retinoic Acid-Induced Ototoxicity During Chemotherapy in Pediatric Acute Promyelocytic Leukemia
by: Jong Hyeon Lee, et al.
Published: (2021-01-01)

Acute promyelocytic leukemia: An experience on 95 Greek patients treated in the all-trans-retinoic acid era
by: Maria Pagoni
Published: (2014-08-01)

ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA
by: Kalliopi Manola, et al.
Published: (2011-01-01)

ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA
by: Maria Pagoni, et al.
Published: (2011-11-01)

Availability of all-trans retinoic acid and support systems for management of acute promyelocytic leukemia in Michigan and Louisiana, USA
by: Sheldon L. Bolds, et al.
Published: (2019-05-01)

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.
by: Yafang Ma, et al.
Published: (2016-01-01)

Thrombocytosis in a patient with acute promyelocytic leukemia during treatment with all‐trans retinoic acid and arsenic trioxide
by: Maryam Habibi, et al.
Published: (2021-04-01)

Exudative hemorrhagic retinopathy related to all-trans retinoic acid differentiation syndrome in a patient with acute promyelocytic leukemia
by: Emily K. Tam, et al.
Published: (2021-02-01)

A Complicated Case of Acute Promyelocytic Leukemia in the Second Trimester of Pregnancy Successfully Treated with All-trans-Retinoic Acid
by: Kanika Agarwal, et al.
Published: (2015-01-01)

Effect of all-trans retinoic acid on newly diagnosed acute promyelocytic leukemia patients: results of a Brazilian center
by: B.C. de-Medeiros, et al.
Published: (1998-12-01)

All-trans-retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis
by: Teresa A. Colvin, et al.
Published: (2018-01-01)

Bradycardia during Induction Therapy with All-trans Retinoic Acid in Patients with Acute Promyelocytic Leukemia: Case Report and Literature Review
by: Pin-Zi Chen, et al.
Published: (2018-01-01)

Administration of all-trans retinoic acid through enteral tubes in acute promyelocytic leukemia: the handling of cytotoxic agents and clinical benefits
by: Lucas Miyake Okumura, et al.

A rare case: coexistence of small cell lung cancer and chronic lymphocytic leukemia
by: M. Tıglıoglu, et al.
Published: (2020-10-01)

All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review
by: Dylan Holmes, et al.
Published: (2012-01-01)

Retinoic acid and arsenic for treating acute promyelocytic leukemia.
by: Guang-Biao Zhou, et al.
Published: (2005-01-01)

Mechanisms of retinoic acid resistance in acute promyelocytic leukemia
by: Nichol, Jessica
Published: (2014)

Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients
by: P. Akyol, et al.
Published: (2020-10-01)

ALL-TRANS RETINOIC ACID-INDUCED MYOSITIS IN A 36-YEAR-OLD PATIENT WITH ACUTE PROMYELOCYTIC LEUKAEMIA
by: M.J. Atanazio, et al.
Published: (2020-11-01)

Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial
by: Xinxin Zhang, et al.
Published: (2018-09-01)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
by: Francesco Autore, et al.
Published: (2021-07-01)

Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial
by: Li Zhang, et al.
Published: (2018-04-01)

Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
by: Valeria Ferla, et al.
Published: (2020-04-01)

The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma
by: B. Saglam, et al.
Published: (2020-10-01)

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide
by: Yang Shen, et al.
Published: (2015-06-01)

The Cytotoxicity Effect of RC-RNase and All-Trans Retinoic Acid on Human Promyelocytic Leukemic HL60 cells
by: Huang, Ting-Han, et al.
Published: (2011)

Disease and clinical characteristics of patients with chronic myeloproliferative neoplasms: 11-year single center experience
by: P. Akyol, et al.
Published: (2020-10-01)

Acute Coronary Syndrome Manifesting as an Adverse Effect of All-trans-Retinoic Acid in Acute Promyelocytic Leukemia: A Case Report with Review of the Literature and a Spotlight on Management
by: K. Govind Babu, et al.
Published: (2016-01-01)

Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia
by: Jacqueline Lehmann-Che, et al.
Published: (2018-05-01)

Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2
by: Károly Jambrovics, et al.
Published: (2020-03-01)

Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
by: Mohammed Al Huneini, et al.
Published: (2013-05-01)

Cannot write session to /tmp/vufind_sessions/sess_aqb1ts8scgsjdcu8l2008e9p66